A Crackdown Comes for Healthcare
Six months into a campaign to rout out corruption from the Chinese healthcare industry, many of the underlying issues in the sector remain unchanged.
Showing 361 - 372 of 1470
The Food Security Gene
A look at how Beijing is shedding its skepticism about GM crops.
Kerry Brown on the Nature of Chinese Power
The academic and former diplomat talks about the need for a more realistic strategy towards China and why the West and Beijing often fail to...
How a Battery Metals Supply Glut is Deepening China’s Dominance
Crashing metals prices are making it hard for Western miners to justify new investments in the minerals needed for clean energy.
The DNA Distortion
ANDE, a U.S. biotechnology company, promised a "faster way to a safer world" with its revolutionary rapid DNA testing machine. But by selling its innovation...
Beijing Is Set to Rescue the Market Again: But Is That the Right Thing to Do?
There are much better ways for the government to spend hundreds of billions of dollars than propping up Chinese stocks.
Biotech Decoupling?
Plus, Victor Shih on China's stock markets.
The Rising Cost of the Climate Crisis
Besides the human cost, natural disasters are causing ever more damage to China’s economy.
Ernest Scheyder on the Tough Choices around Critical Minerals
The journalist discusses the trade-offs involved in sourcing the minerals needed to power the clean energy transition, and how the U.S. fell behind China in...
G42’s China Ties Reveal a Broader AI Debate
How far should the U.S. government go to ensure that adversaries like China can’t catch up on AI?
U.S. Technologies and the Emboldening of China
Rather than restricting access to militarily useful technologies, U.S. export control officials and their failed policies risk emboldening Beijing.
Comeback King?
Don't count Alibaba out yet.